154 related articles for article (PubMed ID: 30715928)
21. Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer.
Onukwugha E; Yong C; Hussain A; Seal B; Mullins CD
BMC Med Res Methodol; 2014 Jan; 14():1. PubMed ID: 24383436
[TBL] [Abstract][Full Text] [Related]
22. Utility of the SEER-Medicare data to identify chemotherapy use.
Warren JL; Harlan LC; Fahey A; Virnig BA; Freeman JL; Klabunde CN; Cooper GS; Knopf KB
Med Care; 2002 Aug; 40(8 Suppl):IV-55-61. PubMed ID: 12187169
[TBL] [Abstract][Full Text] [Related]
23. Comparison of treatment of early-stage breast cancer among Nurses' Health Study participants and other Medicare beneficiaries.
Austin AM; Kapadia NS; Brooks GA; Onega TL; Eliassen AH; Tamimi RM; Holmes M; Wang Q; Grodstein F; Tosteson ANA
Breast Cancer Res Treat; 2019 Apr; 174(3):759-767. PubMed ID: 30607634
[TBL] [Abstract][Full Text] [Related]
24. Utilizing Medicare claims data for real‐time drug safety evaluations:is it feasible?
Hartzema AG; Racoosin JA; MaCurdy TE; Gibbs JM; Kelman JA
Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):684-8. PubMed ID: 21847800
[TBL] [Abstract][Full Text] [Related]
25. Assessing comorbidity using claims data: an overview.
Klabunde CN; Warren JL; Legler JM
Med Care; 2002 Aug; 40(8 Suppl):IV-26-35. PubMed ID: 12187165
[TBL] [Abstract][Full Text] [Related]
26. Methodological issues in the use of administrative claims data to study surveillance after cancer treatment.
Butler Nattinger A; Schapira MM; Warren JL; Earle CC
Med Care; 2002 Aug; 40(8 Suppl):IV-69-74. PubMed ID: 12187171
[TBL] [Abstract][Full Text] [Related]
27. Ability of Medicare claims data to identify nursing home patients: a validation study.
Koroukian SM; Xu F; Murray P
Med Care; 2008 Nov; 46(11):1184-7. PubMed ID: 18953230
[TBL] [Abstract][Full Text] [Related]
28. The use of breast conserving surgery: linking insurance claims with tumor registry data.
Maskarinec G; Dhakal S; Yamashiro G; Issell BF
BMC Cancer; 2002; 2():3. PubMed ID: 11879527
[TBL] [Abstract][Full Text] [Related]
29. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients.
Klabunde CN; Legler JM; Warren JL; Baldwin LM; Schrag D
Ann Epidemiol; 2007 Aug; 17(8):584-90. PubMed ID: 17531502
[TBL] [Abstract][Full Text] [Related]
30. Classifying Stage IV Lung Cancer From Health Care Claims: A Comparison of Multiple Analytic Approaches.
Brooks GA; Bergquist SL; Landrum MB; Rose S; Keating NL
JCO Clin Cancer Inform; 2019 May; 3():1-19. PubMed ID: 31070985
[TBL] [Abstract][Full Text] [Related]
31. Challenges in merging Medicaid and Medicare databases to obtain healthcare costs for dual-eligible beneficiaries: using diabetes as an example.
Prela CM; Baumgardner GA; Reiber GE; McFarland LV; Maynard C; Anderson N; Maciejewski M
Pharmacoeconomics; 2009; 27(2):167-77. PubMed ID: 19254049
[TBL] [Abstract][Full Text] [Related]
32. Medicare claims data reliably identify treatments for basal cell carcinoma and squamous cell carcinoma: a prospective cohort study.
Thompson BS; Olsen CM; Subramaniam P; Neale RE; Whiteman DC
Aust N Z J Public Health; 2016 Apr; 40(2):154-8. PubMed ID: 26558736
[TBL] [Abstract][Full Text] [Related]
33. Incremental value of using Medicaid claim files to study comorbid conditions and treatments in dually eligible beneficiaries.
Bradley CJ; Dahman B; Bataki PM; Koroukian S
Med Care; 2010 Jan; 48(1):79-84. PubMed ID: 20050352
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis date agreement between SEER and Medicare claims data: impact on treatment.
Lin CC; Virgo KS
Med Care; 2014 Jan; 52(1):32-7. PubMed ID: 24322987
[TBL] [Abstract][Full Text] [Related]
35. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
Pauly NJ; Talbert JC; Brown J
J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
[TBL] [Abstract][Full Text] [Related]
36. Predictors of Medicare costs in elderly beneficiaries with breast, colorectal, lung, or prostate cancer.
Penberthy L; Retchin SM; McDonald MK; McClish DK; Desch CE; Riley GF; Smith TJ; Hillner BE; Newschaffer CJ
Health Care Manag Sci; 1999 Jul; 2(3):149-60. PubMed ID: 10934539
[TBL] [Abstract][Full Text] [Related]
37. Validity of claims-based stroke algorithms in contemporary Medicare data: reasons for geographic and racial differences in stroke (REGARDS) study linked with medicare claims.
Kumamaru H; Judd SE; Curtis JR; Ramachandran R; Hardy NC; Rhodes JD; Safford MM; Kissela BM; Howard G; Jalbert JJ; Brott TG; Setoguchi S
Circ Cardiovasc Qual Outcomes; 2014 Jul; 7(4):611-9. PubMed ID: 24963021
[TBL] [Abstract][Full Text] [Related]
38. Identifying specific chemotherapeutic agents in Medicare data: a validation study.
Lund JL; Stürmer T; Harlan LC; Sanoff HK; Sandler RS; Brookhart MA; Warren JL
Med Care; 2013 May; 51(5):e27-34. PubMed ID: 22080337
[TBL] [Abstract][Full Text] [Related]
39. Information gained from linking SEER Cancer Registry Data to state-level hospital discharge abstracts. Surveillance, Epidemiology, and End Results.
Brooks JM; Chrischilles E; Scott S; Ritho J; Chen-Hardee S
Med Care; 2000 Nov; 38(11):1131-40. PubMed ID: 11078053
[TBL] [Abstract][Full Text] [Related]
40. The Design and Validation of a New Algorithm to Identify Incident Fractures in Administrative Claims Data.
Wright NC; Daigle SG; Melton ME; Delzell ES; Balasubramanian A; Curtis JR
J Bone Miner Res; 2019 Oct; 34(10):1798-1807. PubMed ID: 31170317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
